Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03620942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System

Study acronym: ADIVA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2025 → Dec 31, 2026
See other at-risk trials from KK Women's and Children's Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    v11
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v10
  3. Study description shortened, about 2 wordsv9
  4. Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Enrollment target: estimated 300 to confirmed 173
    • Study completion date: Dec 31, 2023 to Dec 31, 2024
    • Study description expanded, about 25 words
    v8
  5. Primary completion date: Dec 31, 2021 to Dec 31, 2022
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2022 to Dec 31, 2023
    • Site details revised
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Primary completion date: Dec 31, 2019 to Dec 31, 2021
    • Study completion date: Dec 31, 2019 to Dec 31, 2022
    v5
  3. Primary and study completion dates: Aug 31, 2019 to Dec 31, 2019v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 20, 2018 to Nov 7, 2018
    • Site details revised
    v3
  5. Start date: Sep 1, 2018 to Oct 20, 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Maternal hypotension during spinal anaesthesia for Caesarean delivery may bring various adverse effects. It is therefore important to closely monitor hypotension during spinal anaesthesia, however current technology does not allow the blood pressure monitoring to respond in timely manner should there be any occurrence of hypotension. The investigators developed an advanced double-intravenous vasopressor automated system (ADIVA) so as to tackle this issue via novel algorithm to control blood pressure more rigorously with more stable haemodynamic profiles.
Trial Details
NCT Number NCT03620942
Lead Sponsor KK Women's and Children's Hospital
Conditions
(from sponsor)		 Hypotension, Anesthesia
Related terms Hypotension
Enrollment 173 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov